Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H9Cl2N3 |
| Molecular Weight | 230.094 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(CN1)C2=CC=C(Cl)C(Cl)=C2
InChI
InChIKey=HNDUFKGYRGYWIT-UHFFFAOYSA-N
InChI=1S/C9H9Cl2N3/c10-6-2-1-5(3-7(6)11)8-4-13-9(12)14-8/h1-3,8H,4H2,(H3,12,13,14)
| Molecular Formula | C9H9Cl2N3 |
| Molecular Weight | 230.094 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antihypertensive activity of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2) and catecholamine reduction. | 1975-09 |
|
| Inhibition of sympathetic activity following chronic administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2). | 1974-10 |
|
| Effect of acute administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline HBr (MJ 10459-2) or guanethidine on selected sympathetically-mediated responses in the anesthetized dog and cat. | 1974-08 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:13:44 GMT 2025
by
admin
on
Mon Mar 31 19:13:44 GMT 2025
|
| Record UNII |
P2Y80FT91F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P2Y80FT91F
Created by
admin on Mon Mar 31 19:13:44 GMT 2025 , Edited by admin on Mon Mar 31 19:13:44 GMT 2025
|
PRIMARY | |||
|
168914
Created by
admin on Mon Mar 31 19:13:44 GMT 2025 , Edited by admin on Mon Mar 31 19:13:44 GMT 2025
|
PRIMARY | |||
|
118909-96-9
Created by
admin on Mon Mar 31 19:13:44 GMT 2025 , Edited by admin on Mon Mar 31 19:13:44 GMT 2025
|
PRIMARY |